Leukemia Research
Volume 27, Issue 3 , Pages 201-203 , March 2003

Is it still possible to ameliorate the diagnosis of refractory anemia?

References 

  1. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, et al.  The French–American–British (FAB) co-operative group. Proposals for the classification of the myelodyplastic syndromes. Br. J. Heamatol. 1982;51:189–199
  2. Gatterman N, Aul C, Schneider W. Two types of acquired idiopathic sideroblastic anemia (AISA). Br. J. Haematol. 1990;74:45–52
  3. Garand R, Gardais J, Bizet M, Bremond JL, Accar F, Goasguen JE. Heterogeneity of acquired idiopathic sideroblastic anemia (AISA). Leuk. Res. 1992;16:463–468
  4. Tefferi A, Hoagland HC, Therneau TM, Pierre RV. Chronic myelomonocytic leukemia: natural history and prognostic determinants. Mayo Clin. Proc. 1989;10:1246–1254
  5. Brito-Babapulle F, Catovsky D, Galton DAG. Clinical and laboratory features of de novo acute myeloid leukaemia with trilineage myelodyplasia. Br. J. Haematol. 1987;66:445–454
  6. Goasguen JE, Matsuo T, Cox C, Bennett JM. Evaluation of the dysmyelopoiesis in 336 patients with de novo acute myeloid leukaemia: major importance of dysgranulopoiesis for remission and survival. Leukemia. 1992;6:520–525
  7. Rosati S, Mick R, Xu F, Stonys E, LeBeau MM, Larson R, et al.  Refractory cytopenia with multilineage dysplasia: further characterization of an unclassifiable myélodyplastic syndrome. Leukemia. 1996;10:20–26
  8. Sanz GF, Sanz MA, Vallespi T, Canizo MC, Torrabadella M, Garcia S, et al.  Twa regression models and a scoring system for predicting survival and planning treatment in myelodyplastic syndromes: a multivariate analysis of prognostic factors in 370 patients. Blood. 1989;74:395–408
  9. Morel P, Hebbar M, Lai JL, Duhamel A, Preudhomme C, Wattel E, et al.  Cytogenetic analysis has a strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases. Leikemia. 1993;7:1315
  10. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, et al.  International scoring system for evaluating prognosis anemia. Leukemia. 1998;89:2079–2088
  11. Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. World Health Organization classification of tumours: pathology and genetics of tomours of haematopoietic and lymphoid tissues. Lyon: IARC Press, 2001.
  12. Germing U, Gattermann N, Strupp C, Aivado M, Aul C. Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients. Leuk. Res. 2000;24:983–992
  13. Cermak J, Michalova K, Brezinova J, Zemanova Z. A prognostic impact of separation of refractory cytopenia with multilineage dysplasia and 5q− syndrome from refractory anemia in primary myelodysplastic syndrome. Leuk Res 2003;27:221–29.
  14. Nösslinger T, Reisner R, Koller E, Grüner H, Tchler H, Nowotny H, et al.  Myelodysplastic syndromes, from French–American–British to World Health Organization: comparison of classifications on 431 unselected patients from a single institution. Blood. 2001;98:2935

PII: S0145-2126(02)00174-1

Leukemia Research
Volume 27, Issue 3 , Pages 201-203 , March 2003

Article Tools